RxDoctor Payments DataLook up a doctor →

James Fidelholtz, MD

Geriatric Medicine · Cincinnati, OHNPI 1245449438

Payments from drug & device makers

$392,171in general payments, 2019–2025

Across 480 payments — averaging $817.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ironwood Pharmaceuticals, Inc$181K
  • Pfizer$111K
  • Acadia Pharmaceuticals Inc$41K
  • Regeneron$26K
  • Swedish Orphan Biovitrum AB$19K
  • AstraZeneca$3K
  • plus $12K from 37 others
$38,439in research payments, 2019–2025

Across 8 payments — averaging $4804.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$38K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$392,171 in reported general payments places this provider in the 95th percentile of 146 geriatric medicine providers in Ohio.

See all geriatric medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$66,477
Medicare patients
165
Services billed
849

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other geriatric medicine in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →